Sunday, November 3, 2024
HomeTagsED

ED

Cytovale Secures $84 Million Series C to Advance Commercialization of Transformative Sepsis Diagnostic Tool

Norwest-led Financing Will Bring FDA-Cleared IntelliSep® Test to Hospitals Nationwide to Support Early Detection and Treatment of Serious Condition Cytovale, a commercial-stage medical diagnostics company focused...

Cytovale® Announces Commercial Launch of IntelliSep® Sepsis Test, the First-of-its-Kind Diagnostic Tool for Emergency Departments

Cytovale, a pioneering medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, announced the U.S. commercial launch of...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics